This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Hanmi Pharm. Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovations of Seon Myeong Lee
Introduction
Seon Myeong Lee is a notable inventor based in Hwaseong-si, Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of respiratory infectious diseases. His innovative approach has led to the development of a unique patent that addresses critical health issues.
Latest Patents
Seon Myeong Lee holds a patent titled "Use of Trigonal Agonist Having Activities to All of Glucagon, GLP-1, and GIP Receptors in Treatment of Sequelae Following Respiratory Infectious Diseases." This patent highlights his commitment to advancing medical treatments and improving patient outcomes.
Career Highlights
Lee is currently employed at Hanmi Pharmaceutical Co., Ltd., where he continues to work on groundbreaking research and development projects. His expertise in pharmacology and innovative thinking has positioned him as a key player in the pharmaceutical industry.
Collaborations
Throughout his career, Seon Myeong Lee has collaborated with talented individuals such as Jung Kuk Kim and Sang Hyun Lee. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of new solutions.
Conclusion
Seon Myeong Lee's contributions to the field of pharmaceuticals exemplify the impact of innovation on healthcare. His work not only addresses pressing medical challenges but also inspires future advancements in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile